ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GSK Gsk Plc

1,599.00
15.50 (0.98%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  15.50 0.98% 1,599.00 1,599.50 1,600.50 1,600.00 1,575.00 1,579.50 5,149,016 16:35:14
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.37 65.87B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,583.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £65.87 billion. Gsk has a price to earnings ratio (PE ratio) of 13.37.

Gsk Share Discussion Threads

Showing 15651 to 15675 of 33100 messages
Chat Pages: Latest  628  627  626  625  624  623  622  621  620  619  618  617  Older
DateSubjectAuthorDiscuss
16/11/2017
10:01
The market for this is huge - COPD is a progressive lung disease that is thought to affect around 384 million people worldwide.
tradermichael
16/11/2017
09:25
when will we go sub £13
billionaire1
16/11/2017
09:24
Trelegy looks a great products, the question atm is not around its efficacy,
it's the price positioning and whether it can build decent share.

essentialinvestor
16/11/2017
09:20
Another good RNS.
spcecks
16/11/2017
09:10
...... and the dividend becomes more affordable. The last two are blockbusters.
tradermichael
16/11/2017
09:01
......and the share price continues to fall.
bili1946
16/11/2017
07:55
Excellent product news accelerates ...... ;0)
tradermichael
16/11/2017
07:53
Trelegy Ellipta once-daily single inhaler triple therapy gains marketing authorisation in Europe for the treatment of COPD

GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Commission has granted marketing authorisation for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol, 'FF/UMEC/VI') as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist.

Trelegy Ellipta is the first once-daily single inhaler triple therapy to be approved in Europe. It is a combination of an inhaled corticosteroid (ICS), a long-acting muscarinic antagonist (LAMA) and a long-acting beta2-adrenergic agonist (LABA), delivered once daily in GSK's Ellipta dry powder inhaler.

tradermichael
15/11/2017
17:10
I have too many of these so keep saying enough is enough, but then the price falls so I buy more. Bought again today at 1309. I cannot really believe it.
jadeticl3
15/11/2017
16:41
Pipeline better focused now than it was when it was at £17+
romeike
15/11/2017
13:54
Yes guys but it's surely fair value now?
mj19
15/11/2017
13:39
Monty, it's the pipeline as well imv.

That oncology compound needs to continue to advance through trials.

essentialinvestor
15/11/2017
13:37
MJShould also opened her big mouth about possible bid for Pfizer heath div.Hope she does not player poker, she would show her cards. Naive.
montyhedge
15/11/2017
13:36
Woodhawk - "Decided to add some more myself - averaging down from £13.60. Crazy"

Depends on your time scale, lot of people on here count in days or maybe weeks, but some are long term and look to next year or even (as the institutions are always saying) five years. Good luck with your purchase.

losos
15/11/2017
13:36
You know is what the old City saying is ... Everyone is a genius in a bull market! ).

A tad tougher when markets begin to turn.

essentialinvestor
15/11/2017
13:29
woodhawk - "My entire portfolio has doubled in less than three years through capital gains and reinvested dividends."

Well you've done better than me, mind you that's not difficult haha.

losos
15/11/2017
12:33
Looks like it may want sub £13, let's see
essentialinvestor
15/11/2017
12:12
This is a strong buyMs Walmsley warned GSK was "moving forward with contingency planning right now" and would start spending within weeks on drawing up plans for duplicate medicine testing centres in the EU and preparing for separate drug licensing regimes – both of which would be needed in the event of a so-called "hard Brexit".GSK wants Brexit transition arrangements of "at least two years", Ms Walmsley said. She said she did not expect the Brexit-related costs to be material to its results.
mj19
15/11/2017
12:08
Yes but shorters are never satisfied!
abdullla
15/11/2017
10:18
Surely everything for now is priced in?
mj19
15/11/2017
10:17
Decided to add some more myself - averaging down from £13.60. Crazy.
woodhawk
15/11/2017
10:14
So we have resistance at 1324 and support at 1310 for now
mj19
15/11/2017
10:01
Nice buying NY Boy.
woodhawk
15/11/2017
09:57
Ignore the noise, added more this morning, I love a bargain to tuck away and happy to collecting quarterly divis 6.08% per ammun thank you very much! Gift of the year
ny boy
15/11/2017
08:23
Thanks TM,got them but sadly sitting on a loss,waiting for a blessing in disguise and divi!
abdullla
Chat Pages: Latest  628  627  626  625  624  623  622  621  620  619  618  617  Older

Your Recent History

Delayed Upgrade Clock